Tested stronger pain-blocking shot for knee replacement surgery
Part of Bones, joints & muscles, Pain clinical trials.
This Phase 2 study compares two ways to reduce pain after total knee replacement (TKA): a steroid-enhanced nerve block versus a numbing shot called Exparel. It aims to see which option improves comfort and recovery after surgery done with spinal anesthesia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a first-time, elective, bilateral total knee replacement (both knees), for osteoarthritis
- Your anesthesia plan is spinal anesthesia using plain 0.5% bupivacaine
- You are able to give consent and complete follow-up questionnaires by phone or online (or by email)
- You have no reason you can’t use the study medicines (acetaminophen, Celebrex, bupivacaine, DEX, MPA, or LB)
- You do not have bleeding problems, immune system problems, or a current/nearby infection at the nerve block site or in your body
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study compares two ways of reducing nerve pain after knee replacement surgery (total knee arthroplasty). It looks at whether steroid-enhanced pain medicine works better than a different numbing injection to improve recovery and comfort.
This trial tests two different numbing medicines for knee replacement surgery. It compares a long-acting numbing medicine (liposomal bupivacaine) with a standard one (ropivacaine) mixed with other drugs to see which provides better pain control. The goal is to find a way to reduce pain and improve recovery.
This study tests a new way to deliver pain medication during and after knee replacement surgery. Researchers compare injecting a long-acting numbing medicine (EXPAREL) directly into the knee joint versus spreading it through the surgical area, to see which method works better for pain control.
This study compares two ways to manage pain after total knee replacement: one uses a long-lasting numbing medicine, the other uses extra medications during nerve blocks. The goal is to find which method provides better pain relief and recovery.
This study tests a long-lasting numbing medicine (liposomal bupivacaine) injected around the knee during total knee replacement surgery. It aims to see if this medicine helps control pain and reduce the need for other painkillers after surgery.
This trial tests two different drugs (dexamethasone and dexmedetomidine) added to a standard nerve block for knee replacement. It aims to see which one provides better pain control after surgery.
Hear when a new Total Knee Replacement trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.